Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

• Main Authors: Adam M. Bressler (Author), Ali A. Hassoun (Author), Louis D. Saravolatz (Author), Valerie Ravenna (Author), Chris N. Barnes (Author), Bibiana Castaneda-Ruiz (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Telavancin-a lipoglycopeptide antibacterial agent active against Gram-positive pathogens including methicillin-sensitive and -resistant Staphylococcus aureus (MRSA)-is approved in the USA for once-daily intravenous use. This registry study captured patient characteristics, prescr...